All fields are required.

Request Information
Organisation accreditated by Association for the Accreditation of Human Research Protection Program Locations at Delhi, Chennai, Hyderabad, Ahmedabad, Madhurai.

Clinical Research

Over 800 Clinical Trials – 15 Sites

Clinical Research

Clinical trials:

ARI is India's first and single largest site solutions organization (SSO) having experience of coordinating conduct of over 850 clinical trials across 10 locations and 17 sites, various therapeutic disciplines over the last 16 years. 17 sites, With the current strength of almost 80 certified and experienced Clinical Research Coordinators and 200 Principal Investigators on its panel across 15 sites, ARI ensures ethical conduct of clinical research across the hospital group. ARI conducts phase II, III and IV clinical trials, of which 80% are global multi-­centric trials.

ARI has developed the capability to now conduct clinical studies for drugs, devices, software applications and others. Further, ARI works with its clients and partners with a variety of creative business models to enable progressive and quality research.

ARI has established a benchmark in terms of ethics compliance and standards across its sites. . The Institutional Ethics Committees at each of the Apollo Hospital centers are registered with the national regulatory agency and institutional ethics committees at Chennai and Hyderabad are also OHRP registered. ARI also has built an in-house capability in ethics and quality assurance for clinical trials across multiple sites.

The Institutional Ethics Committees in all the 10 Apollo Hospital locations are registered with the Drug Control General of India (DCGI). ARI currently is coordinating the conduct of almost 100 clinical studies across Apollo hospitals.

ARI is now accredited by AAHRPP; the global gold standard in clinical trials. We are the only hospital group getting a simultaneous accreditation for 5 hospitals together. Even AAHRPP is doing this for the first time. This allows Apollo to be prepared better for global clinical studies.

ARI has developed the capability to now conduct clinical studies for drugs, devices, software applications and others. Further, ARI works with its clients and partners with a variety of creative business models to enable progressive and quality research.

Our Trial Experience

Drug Trial: Phase 2
14%
Drug Trial: Phase 3
66%
Drug Trial: Phase 4
15%
Others Studies
5%

Others studies include Observational study, Device, FMCG & Software etc...





Our Trial Experience

Oncology
80%
Cardio Vascular
60%
Diabetology & Endocrinology
30%
Neurology
30%
Others
75%

Trials conducted across all medical disciplines.

Oncology, Cardiology, Neurology, Diabetology & Endocrinology form the Major trial categories.